Related Experiment Video
Updated: Sep 15, 2025
Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids
Published on: October 14, 2019
Small Cell Type Poorly Differentiated Neuroendocrine Cancer of the Gallbladder
Akansha1, Madhumita Tripathi2, Roli Purwar2
1Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, IND.
Neuroendocrine carcinoma (NEC) of the gallbladder (GB) is rare. This case study highlights palliative chemotherapy as a feasible option for advanced GB NEC when surgery is not possible.
Area of Science:
- Oncology
- Gastroenterology
Background:
- Neuroendocrine tumors (NET) are rare gallbladder (GB) malignancies with limited clinical data.
- Understanding the presentation and management of GB NET is crucial due to its rarity.
Observation:
- A 62-year-old woman presented with jaundice as the sole symptom.
- Investigations revealed poorly differentiated neuroendocrine carcinoma (NEC) of the GB with advanced invasion and peritoneal metastasis.
Findings:
- Surgical resection, the primary treatment for GB NET, is often not feasible due to metastatic disease at presentation.
- Palliative chemotherapy was administered as the management strategy for this advanced case.
Implications:
- This case underscores the importance of considering chemotherapy for advanced or metastatic GB NEC.
- Further research is needed to establish optimal treatment protocols for this rare malignancy.
More Related Videos
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
